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Abstract
Monomolecular drug carriers based on calix[n]-arenes and -resorcinarenes containing the
interior cavity can enhance the affinity and specificity of the osteoporosis inhibitor drug zole-
dronate (ZOD). In this work we investigate the suitability of nine different calix[4]-arenes and
-resorcinarenes based macrocycles as hosts for the ZOD guest molecule by conducting ab ini-
tio density functional theory calculations for structures and energetics of eighteen different
host-guest complexes. For the optimized molecular structures of the free, phosphonated, sul-
fonated calix[4]-arenes and -resorcinarenes, the geometric sizes of their interior cavities are
measured and compared with those of the host-guest complexes in order to check the appro-
priateness for host-guest complex formation. Our calculations of binding energies indicate
that in gaseous states some of the complexes might be unstable but in aqueous states almost
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Figure 1: Chemical structures of (a) zoledronate and (b) calix[4]arene.
all of the complexes can be formed spontaneously. Of the two different docking ways, the
insertion of ZOD with the P−C−P branch into the cavity of host is easier than that with the
nitrogen containing heterocycle of ZOD. The work will open a way for developing effective
drug delivering systems for the ZOD drug and promote experimentalists to synthesize them.
Introduction
Zoledronic acid (or zoledronate: ZOD) is a third generation of bisphosphonates (BPs), being
widely used as a successful drug in the treatment of patients with bone diseases such as osteo-
porosis and metabolic bone disorders. It consists of two phosphonate groups (−PO(OH)2), central
carbon atom between them and two side groups of hydroxyl group and heterocyclic group con-
taining two nitrogen atoms, as shown in Figure 1(a). The operation of ZOD can be explained
by that the P−C−P backbone of ZOD has a high binding affinity to bone mineral hydroxyapatite
(HAP) due to a structural analog with the P−O−P part of HAP, and is more resistant to chemical
and enzymatic hydrolysis than the P−O−P group of pyrophosphate of HAP, while the nitrogen-
containing heterocyclic group of ZOD has a strong antiresoptive potency to inhibit the activity of
osteoclast.1–7 With a constant continuation of seeking for effective BPs that have a strong efficacy,
it is also desirable to develop a drug carrier, with which the ZOD drug can reach the disordered
bone without any loss, which can reduce the amount of drug dosage and eliminate possible side
effects by uneven drug biodistribution.
In fact, drug delivery with a high specific affinity towards a pathological tissue is an impor-
tant complement to drug discovery.8,9 Many drug delivering systems with clinical approval have
been developed. Supramolecular polymeric micelles or encapsulation are a traditional choice for
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this aim, but there still remains a challenge of including a drug molecule by a single delivering
host on a 1:1 stoichiometry. Since large molecular weights may originate some diffusion incon-
venience, macromolecular carriers have been suggested to address the issues such as specificity
and molecular weight. Moreover, monomolecular drug carriers can provide drug molecules with
a higher sustaining potency without hampering too much their diffusion between cells within the
pathological tissue. Supramolecular macrocycles with a cavitand such as crown-ethers, cryptands,
cyclodextrins, calixarenes and calixresorcinarenes have been developed during the past decades
and attempted to utilize as drug carriers. Among them, calixarenes and calixresorcinarenes are
considered to be the third generation of macrocycles beyond cyclodextrins and crown-ethers.
Calix[n]arenes (or calix[4]resorcinarenes) are a well known class of macrocyclic compounds
that have a bowl or cone shaped cavity (see Figure 1(b) for calix[4]arene), and can be obtained
in very high yield through a condensation of formaldehyde with p-substituted phenol derivatives
in basic conditions.10–12 In respect of structural characteristics, they are composed of three parts;
a wide upper rim, a narrow lower rim, and a central annulus (phenol- or resorcinol-derived cy-
clooligomers). Both rims can be easily modified with a variety of functional groups, such as
hydrophilic long-chain organic polymer at the lower rim and hydrophobic inorganic group at the
upper rim. In addition, a plenty of conformations are possible for the macrocyclic backbone, of
which the number increases with the number of phenolic units n, depending on their functional-
ization. For instance, the most widely studied calix[4]arene has four major distinct conformers.13
All these unique structural features provide a large flexibility of calixarenes, which in turn promise
versatile hosts for various guest molecules with a broad range of size in host-guest chemistry. Their
abilities to form host-guest complexes make it possible to use in nonlinear optical chromophores,
ion receptors, ion selective electrodes and molecular recognition devices,14–16 but they have at-
tracted much more interest in drug design and delivery.17–20 Indeed, the amphiphilic calixarenes,
containing two rims as antipodal blades (hydrophobic and hydrophilic segments linked by non-
covalent bond), can serve as carriers for many guest drugs employing the host-guest interaction.
Moreover, water-soluble calixarenes due to the hydrophilic lower rim can include hydrophobic
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drug molecule from aqueous solution with their hydrophobic upper rim, and thus enhance solu-
bility and bioavailability of the drug. When the host-guest system contacting with the targeted
cell, the drug molecule interacts with the cell, while the remained calixarenes should be eliminated
from the body without any side effect. In this context, it is also fortunate that calixarenes show little
non-toxicity.17,21–23 Drug delivery and solubilization using calix[n]arenes or calix[4]resorcinarenes
have been reported.24–31,31–38 However, the use of calixarenes and calixresorcinarenes as drug de-
livery is still a relatively novel concept, and the number of experimental or computational studies
reported so far is relatively low, despite that these macrocyclic compounds possess several advan-
tages such as ease of synthesis and modification and low toxicity.
In this work, we consider the free, phosphonated and sulfonated calix[4]-arenes and -resorcinarenes
as hosts, the ZOD molecule as a guest and their possible host-guest complexes to get an insight
for the formation of host-guest complexes. Systematic density functional theory (DFT) calcula-
tions are carried out for structural optimizations and energetics in combination with a conformation
searching method, as already simulation works reported for interactions between calixarenes and
other drug molecules.39–49
Computational method
We consider calix[4]arene and calix[4]resorcinarene as parent hosts, while applying phosphonated
(−PO(OH)2) and sulfonated (−SO2OH) modifications at the upper rim for both cases, and methyl
group (−CH3) modification at the lower rim for the latter case to build further plausible hosts.
Among four different conformations for calix[4]arene,13 only the so-called cone conformation was
utilized since this conformation has the lowest total energy compared with other conformations.
Using the ZOD molecule as a guest, we build the host-guest complexes by manually docking
the guest through either the P−C−P branch or the nitrogen-containing heterocyclic ring of ZOD
inside the host cavity from the upper rim, as depicted in Figure 2. We suggest monomolecular
drug carrier host and ZOD drug guest on a 1:1 stoichiometry in this work. From a geometric
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Figure 2: Docking orientations of ZOD within the host cavities of calix[4]arene.
consideration, the insertion of the drug molecule from the lower rim can not be hypothesized.
The above procedure yields nine different hosts and eighteen host-guest complexes. In order to
denote the complexes concisely, we adopt a notation of host@guest, where for the host Cal and
Res are used for calix[4]arene and calix[4]resorcinarene, prefix P- and S- for the phosphonated and
sulfonated modifications, suffix -m for methyl modification, and for the guest branch and ring are
used to distinguish the two different docking ways of ZOD. For instance, S-Res-m@branch is for
the complex of sulfonated calix[4]resorcinarene combined with ZOD at the P−C−P branch.
The resulting crude structures are first refined through a conformational search to derive the
lowest energy conformation by using the Conformers module in the Materials Studio package.
Stochastic searching approach that employs random generation of conformational parameters were
chosen as an algorithm, where each torsion angle is randomly assigned a value in the certain range.
The obtained conformations are then optimized using the ab initio pseudopotential-pseudo atomic
orbital (PAO) method within the framework of DFT, as implemented in the SIESTA code.50 We
constructed the Troullier-Martins type norm-conserving pseudopotentials51 of all atoms using the
ATOM code provided in the SIESTA package, where the valence electronic configurations are
C-2s22p23d04 f 0, O-2s22p43d04 f 0, H-1s12p03d04 f 0, S-3s23p43d04 f 0, N-2s22p33d04 f 0, and P-
3s23p33d04 f 0. Transferability testings are performed for these generated pseudopotentials. The
standard double-ζ and polarized (DZP) basis sets for PAOs of all the atoms are used, where the
energy shift for orbital-confining cutoff radii is 300 meV and the split norm for the split-valence
of basis is 0.25. The BLYP52,53 functional within the generalized gradient approximation (GGA)
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is used for the exchange-correlation interactions between the valence electrons. We consider dis-
persive van der Waals (vdW) interactions between molecules by employing the semi-empirical
Grimme’s approach and using the necessary parameters provided therein.54 The energy cutoff to
set the wavelength of the shortest plane wave represented on the real grid, which controls the mesh
size of grid, is set to be 300 Ry. In the structural optimizations, the atoms are relaxed until the
exerted forces converge less than 0.02 eV/Å. The three-dimensional periodic supercells with cubic
symmetry are used to make modeling for isolated molecules. Lattice constants of these cubic su-
percells are 40 Å, which can provide long distance (∼30 Å) enough to prevent artificial interactions
between periodic images of molecule.
Result and discussion
We first present the structures of the nine host macrocycles as drug carriers, optimized with DZP
basis sets and the BLYP-GGA functional with the inclusion of vdW correction. Figure 3 shows
the optimized atomistic structures of calix[4]arene and calix[4]resorcinarenes, which are the most
familiar and widely studied calixarenes, and their phosphonate and sulfonate derivatives. We only
considered the cone conformation among four different conformations such as cone, partial cone
(paco), 1,2-alternate and 1,3-alternate,10,13 considering that it is the most stable due to the lowest
Table 1: Width, depth and tilt angle in the interior cavity of the 9 host compounds, depicted in
Figure 3.
Width (Å) Depth Tilt angle
Compound Upper Lower (Å) (deg)
Cal 10.06 4.12 4.35 124
P-Cal 10.47 4.16 6.37 122
S-Cal 10.34 4.20 6.28 121
Res 10.32 4.22 3.86 128
P-Res 10.51 4.37 6.05 123
S-Res 10.72 4.27 5.86 125
Res-m 10.36 4.17 3.81 129
P-Res-m 10.49 4.33 6.00 123
S-Res-m 10.76 4.27 5.86 126
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Figure 3: Atomistic structures of the hosts optimized with DZP basis sets and BLYP
+ vdW (Grimme) functional. (a) Free, phosphonate and sulfonate calix[4]arenes, (b)
calix[4]resorcinarenes and (c) calix[4]resorcinarenes with CH3 modification at the lower rim. Top
and side views are presented.
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total energy and in particular it has the interior cavity with a shape of bowl that is necessary to form
a host-guest couple. Calix[4]arenes consist of four phenolic residues bridged by methylene groups
and hydroxyl groups forming hydrogen bonds at the lower rim, whereas calix[4]resorcinarenes are
a related class of cyclic tetramers prepared by reacting resorcinol with an aldehyde. It is possible
to fix the calix[4]resorcinarene into the cone-like structure by adding additional methylene groups
between the phenolic oxygen atoms, forming a generic structure known as a cavitand. The interior
cavity of calix[4]arene and calix[4]resorcinarene, which is in general hydrophobic in nature, should
be sufficiently deep or wide in order to embrace small organic drug molecule, forming reversible
host-guest complexes, and this can be achieved by adding functional groups such as phosphonate
or sulfonate at the upper rim as we did in this work. We measure the geometrical characteristics
(width at the upper and lower rims, depth, and tilt angle, as depicted in Figure 3(a)) of the interior
cavity. Table 1 shows the corresponding average values in the optimized structures. It was observed
that the largest upper width are found in P-Cal (10.47 Å), S-Res (10.72 Å) and S-Res-m (10.76 Å),
while the largest lower width is found in S-Cal (4.20 Å), P-Res (4.27 Å) and P-Res-m (4.33 Å).
The phosphonate and sulfonate derivatives have ∼2 Å larger depth than free compounds, and the
phosphonate derivatives have slighter larger depth than the sulfonate ones. In addition, the cavity
of free hosts is a little more inclined than that of functionalized hosts. When compared with the
geometry of ZOD molecule that has longer width of 7.13 Å at the branch, width of 4.22 Å at the
ring, and length of 7.11 Å, all the nine hosts have the appropriate cavity size.
Then we analyze the atomistic structures of the host-guest complexes comprised of the above
mentioned hosts and the guest ZOD molecule. There are two different docking ways according to
the orientation of ZOD insertion inside the cavity in each case of the 9 different hosts, (1) insertion
of ZOD with the P−C−P branch pointing inwards the cavity in the direction of the lower rim
and (2) with the heterocyclic ring in the same way as for the first case, resulting in the different
18 host-guest complexes. In Table 2 we show the geometric features of the interior cavity in
the supramolecular host-guest complexes. It was found that when compared with two different
docking ways for the cases of free hosts, there is little change in the upper width (and the tilt
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Table 2: Width, depth and tilt angle in the interior cavity of the 18 host-guest complexes.
Width (Å) Depth Tilt angle
Compound Upper Lower (Å) (deg)
Cal@branch 10.06 4.16 4.38 124
Cal@ring 10.06 4.13 4.35 124
P-Cal@branch 10.92 3.99 6.25 126
P-Cal@ring 10.79 4.07 6.31 124
S-Cal@branch 10.93 4.09 6.14 125
S-Cal@ring 10.82 4.11 6.24 125
Res@branch 10.32 4.20 3.86 128
Res@ring 10.32 4.53 3.96 126
P-Res@branch 10.76 4.56 5.96 124
P-Res@ring 10.63 4.50 6.06 123
S-Res@branch 10.91 4.27 5.74 127
S-Res@ring 10.79 4.58 5.95 124
Res-m@branch 10.37 4.35 3.86 128
Res-m@ring 10.38 4.57 3.92 127
P-Res-m@branch 10.81 4.53 5.93 124
P-Res-m@ring 10.63 4.50 6.06 123
S-Res-m@branch 10.91 4.41 5.81 126
S-Res-m@ring 10.85 4.74 5.97 124
angle) of the cavity, which might be the most changeable geometric factor upon the host-guest
coupling, while the lower width and depth in the branch docking way are smaller and larger than
in the ring way for the resorcinarenes although little change for the calixarenes. Meanwhile, the
cavity of the phosphonato- and sulfonato-hosts coupled with the ZOD guest in the branch way is
clearly wider at the upper rim, shallower, and more inclined than in the ring docking way, whereas
there is no distinction in lower widths between the two different docking ways. On the other hand,
when compared with the hosts before coupling, it can be said that there is little change in the
cavity geometry for the free hosts upon host-guest formation, although small amount of changes
were observed in the lower width. On the contrary, for cases of the hosts functionalized with
phosphonate and sulfonate at the upper rim, the cavity became significantly wider, deeper and
more inclined upon insertion of ZOD molecule. These indicate that there is strong interaction and
thus binding between the functionalized hosts and ZOD molecule, while weak interaction for the
free hosts.
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Figure 4: Optimized structures of host-guest complexes formed by free, phosphonato- and
sulfonato-calix[4]arenes as hosts and ZOD as guest in top (upper panel) and side (lower panel)
views. Docking is constructed by (a) the P−C−P branch of ZOD and (b) the heterocyclic ring
coupled with the upper rim of calixarenes.
Figure 4 shows the optimized structures of host-guest complexes formed by free, phosphonato-
and sulfonato-calix[4]arenes and ZOD molecule. For the cases of branch docking ways, we can
see several hydrogen bonds between ZOD branch oxygen atoms and hydrogen atoms of the host
upper rim, and additionally for the cases of phosphonate and sulfonate derivatives between ZOD
hydrogen atoms and oxygen atoms of the host upper rim, resulting in the hydrogen-mediated bind-
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ing between host and guest. We measured hydrogen bond lengths for the former hydrogen bond
as 2.69, 2.86 Å for Cal@branch, 2.84, 3.10 Å for P-Cal@branch, and 2.90, 3.04, 3.10 Å for
S-Cal@branch, while for the latter hydrogen bond as 2.19, 2.60, 2.88 Å for P-Cal@branch and
2.54, 2.46 Å for S-Cal@branch. For the case of ring docking way, meanwhile, the hydrogen bond
was formed between the ZOD branch and the host upper rim for functionalized calix[4]arenes,
whereas it can not be formed in Cal@ring due to quite long separation (>3.5 Å) between the ZOD
ring nitrogen and the host upper rim hydrogen. The hydrogen bond lengths were measured to
be 2.08, 2.76, 2.92 Å for P-Cal@ring and 2.57, 2.59, 2.60, 2.64, 2.65, 3.01 Å for S-Cal@ring,
which indicates that the latter case has stronger binding than the former case due to more hydrogen
bonds. It is worth noting that the distance between the ZOD ring carbon atoms and the host phenyl
carbon atoms are 2.97, 3.20, 3.50 Å for Cal@ring, 3.09, 3.26, 3,34 Å for P-Cal@ring and 3.47,
3.50 Å for S-Cal@ring, indicating pi − pi stacking interaction between the ZOD heterocyclic ring
carbon atoms and the host phenyl ring carbon atoms. Therefore, we can predict that the host-guest
formation with the ring docking way is preferable to the branch docking way with respect to the
intermolecular interaction.
Similar arguments to the above cases of calix[4]arenes hold for calix[4]resorcinarenes and
their modifications with methyl groups −CH3 at the lower rim. Unlike the calix[4]arenes, they
have additional OH groups at the upper rim, which are from resorcinol, and thus further hy-
drogen bond was formed between these O atoms and the ZOD branch H atoms. In Figure 5,
we show the optimized structures of host-guest supramolecular complexes comprised of free,
phosphonato- and sulfonato-calix[4]resorcinarenes and ZOD molecule. The shortest O· · ·H hy-
drogen bond lengths are 1.78, 1.95, 2.09, 2.11, 2.08, 2.07 Å for Res@branch, P-Res@branch,
S-Res@branch, Res@ring, P-Res@ring, and S-Res@ring, respectively. Typically, these bond
lengths are shorter than those in the corresponding calix[4]arene host-guest complexes, indicat-
ing stronger binding between host and guest. For the pi − pi stacking interaction in the ring dock-
ing cases, the shortest C−C distances are measured to be about 2.6, 2.6, 2.7 Å for Res, P-Res
and S-Res, respectively. Figure 6 shows the optimized molecular structures of host-guest com-
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Figure 5: Optimized structures of host-guest complexes formed by free, phosphonato-and
sulfonato-calix[4]resorcinarenes and ZOD.
plexes from calix[4]resorcinarenes modified with methyl groups at the lower rim. Again, the
hydrogen bond lengths and C−C distances for pi − pi stacking interaction similar to the cases of
calix[4]resorcinarenes were observed. It should be noted that when compared with the Cal@ring,
both Res@ring and Res-m@ring have deeper insertion of the guest ZODmolecule inside the cavity
due to possibly OH groups at the upper rim, indicating stronger binding between host and guest.
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Figure 6: Optimized structures of host-guest complexes formed by free, phosphonato- and
sulfonato-calix[4]resorcinarenes modified by CH3 group at the lower rim and ZOD.
To sum up the structural analysis, (1) the geometrical size of the cavity of phosphonate and
sulfonate modified hosts are clearly changed upon the insertion of guest ZOD molecule inside
their cavity, but little change for the free hosts, (2) the calix[4]resorcinarenes support stronger
binding of host-guest coupling than the calix[4]arenes due to additional hydrogen bonding by OH
groups from resorcinol at the upper rim, and (3) the host-guest formations at the ring docking way
is more desirable than the branch way due to additional pi − pi stacking interaction between the
13
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Figure 7: Bar chart of HOMO and LUMO energy levels in ZOD and calix[4]-arene and -
resorcinarene related compounds, calculated with BLYP + vdW (Grimme) approach in aqueous
state. The corresponding HOMO-LUMO energy gaps in eV unit are presented in the top.
ZOD ring carbon atoms and the host phenyl ring carbon atoms. However, these conclusions are
only qualitative but not quantitative. The quantitative assess for the ease of host-guest formation
can be done by estimating energetics such as binding energy and energy gap between the highest
occupied and lowest unoccupied molecular orbital (HOMO-LUMO) in the following arguments.
The binding energy of ZOD guest to the calix[4]arenes and calix[4]resorcinarenes and their dif-
ferent derivatives were calculated as the difference between total energy of host-guest complexes
and the total energy sum of individual host and guest molecules. In fact, it is regarded that accurate
ab initio calculation of binding energies in supramolecular complexes, in which the non-covalent
pi− pi interactions between conjugated aromatic rings play a key role, is challenging due to the del-
icate balance between different types of intermolecular interactions.47 In this work we considered
dispersive vdW interactions through empirical Grimme’s approach, but we should note that more
accurate description of dispersive interaction is possible with the many-body dispersion method to
capture the anisotropy and collective nature of long-range correlation in supramolecular systems.
Therefore, we will see only whether the host-guest complexes can be formed or not and which
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Table 3: Binding energy (Eb) in gaseous and aqueous state, and HOMO-LUMO energy gap in the
18 host-guest complexes.
Eb (kcal/mol) Energy gap
Compound Gaseous Aqueous (eV)
Cal@branch 3.38 −40.46 3.38
Cal@ring 1.72 −26.42 3.29
P-Cal@branch −46.86 −89.34 3.03
P-Cal@ring −39.48 −85.25 3.46
S-Cal@branch −50.55 −85.37 2.69
S-Cal@ring −38.60 −82.55 3.12
Res@branch −17.94 −62.82 3.18
Res@ring 5.84 −58.15 2.80
P-Res@branch 2.86 −62.40 2.47
P-Res@ring 1.29 −62.13 2.58
S-Res@branch −34.74 −92.89 2.57
S-Res@ring 9.92 −54.71 2.15
Res-m@branch 9.67 −52.20 3.05
Res-m@ring 9.46 −56.53 2.93
P-Res-m@branch 8.57 −56.41 2.63
P-Res-m@ring 6.30 −59.80 2.62
S-Res-m@branch −32.00 −91.83 2.49
S-Res-m@ring 14.45 −50.83 2.16
complex or docking way is more appropriate for the complex formation. In addition, considering
that the reactions are occurred in an aqueous solution, we treated the effect of the solution on the
binding energy using the conductor-like screening model (COSMO)55 with a dielectric constant
78.54 of water. Namely, we considered binding energetics in gaseous and aqueous states.
The calculated binding energies in the 18 different host-guest complexes, together with their
HOMO-LUMO gaps, are listed in Table 3. We were aware of that in the gaseous state only some
host-guest coupling complexes are exothermically formed, such as P-Cal and S-Cal at both branch
and ring sides, Res@branch, S-Res@branch, and S-Res-m@branch, due to their negative binding
energies, and the remaining compounds have positive binding energies, indicating endothermic
formations. Interestingly, for the cases of calix[4]arenes, free hosts can not bind ZOD molecule,
while phosphonato- and sulfonato-calix[4]arenes can bind ZOD in thermodynamically favorable
way, with binding energies of −38 ∼ −50 kcal/mol. When included the aqueous solution effect, we
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have all of the negative binding energies. In both gaseous and aqueous states, the P−C−P branch
docking way is easier to realize host-guest formation than the heterocyclic ring way, with 2 ∼ 3
kcal/mol higher interaction energies for P-Cal, S-Cal, P-Res, Res-m, P-Res-m, and even 20 ∼ 40
kcal/mol higher interaction energies for Cal, Res, S-Res and S-Res-m. Notably, S-Res@branch and
S-Res-m@branch have the largest binding energies of over −90 kcal/mol in aqueous state among
entire host-guest complexes and even in gaseous state they have specially negative binding energies
of about −30 kcal/mol among calix[4]resorcinarene related host-guest complexes. When compared
with other calix[n]arene based drug carriers, calix[n]arene derivatives (R = −OEt, SO2OH; n = 4,
5, 6) coupled with a chemotherapeutic agent GTP have binding energies in the range of −25 ∼
−102 kcal/mol, and moreover, sulfonate calixarenes have superior binding energetics to ethoxyl
calixarenes, e.g., −90.8 kcal/mol for calix[4]arene tetrasulfonic acid with GTP,39 in accordance
well with our calculations.
The frontier molecular orbitals including HOMO and LUMO are important properties that can
be obtained from computational quantum chemistry. The HOMO-LUMO energy gap determines
stability, chemical bonding, electrical and optical properties of the molecule. The smaller energy
gap indicates in general the lower kinetic stability but the better electric conduction. It is also
possible to assess the electron giving and accepting ability of the molecule by considering spatial
distribution of HOMO and LUMO, which characterizes chemical bonding in the molecule. In Fig-
ure 7 we show the bar chart of HOMO and LUMO energy levels in all of the molecules treated
in this work, together with the corresponding HOMO-LUMO energy gaps, calculated in aqueous
states. At the first seeing, the order of HOMO and LUMO energy levels are free < phosphonate
< sulfonate, but the energy gaps have the reverse order like free > phosphonate > sulfonate. It
is found that while ZOD molecule has distinctly large energy gap of 4.8 eV (HOMO; −5.6 eV,
LUMO; −0.8 eV), calix[4]-arene and -resorcinarene related hosts and host-guest complexes have
smaller energy gaps in a range of 2.2 ∼ 3.7 eV. And the energy gaps of the hosts are in gen-
eral larger than those of the corresponding host-guest complexes. Moreover, calix[4]arenes have
slightly larger energy gaps than calix[4]resorcinarenes, whereas there is no clear change between
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Figure 8: Isosurface map of HOMO and LUMO of ZODmolecule, sulfonato-calix[4]resorcinarene
host molecule, and sulfonato-calix[4]resorcinarene coupled with ZOD at the branch and ring, eval-
uated at ±0.03 eV. Yellow color represents the positive value, while blue color the negative value.
calix[4]resorcinarenes and methyl modified calix[4]resorcinarenes. It should be stressed that S-
Res@ring and S-Res-m@ring have the lowest energy gaps of ∼ 2.2 eV (HOMO; −4.8 eV, LUMO;
−2.6 eV). Together with the above analysis for binding energies as well as geometrical size of
cavity, these let us pick the sulfonato-calix[4]resorcinarenes as the most appropriate hosts for ZOD
guest molecule to make formation of S-Res@branch or S-Res@ring complexes.
Figure 8 shows 3-dimensional isosurface map of HOMOs and LUMOs of ZOD, S-Res, S-
Res@branch and S-Res@ring. For the cases of ZOD and S-Res, HOMOs are found on the ZOD
heterocyclic ring and the S-Res phenyl rings, while the majority of LUMOs on the ZOD branch
and the S-Res sulfonate groups. After formation of the host-guest complexes, we observe clearly
different features between branch and ring docking ways; for the branch way HOMOS and LU-
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Figure 9: Isosurface map of electrostatic potential of ZOD molecule, sulfonato-
calix[4]resorcinarene host molecule, and sulfonato-calix[4]resorcinarene coupled with ZOD,
evaluated at 0.045 eV. Yellow color represents the positive value, while blue color the negative
value.
MOS are distributed on the opposite sides of the host annulus, while for the ring way HOMOs on
the heterocyclic ring as in the case of free ZOD molecule and LUMOs on the host side. Similar
features are also observed in other host-guest complexes. This indicates that for the cases of ring
docking way the heterocyclic ring of ZOD plays a role of electron donor, while the phenyl ring part
of hosts the electron acceptor, indicating stronger coupling than for the cases of branch docking
way in respect of host-guest interaction.
The interaction between host and guest in supramolecular complexes can also be characterized
by electrostatic potential map, as shown in Figure 9 for sulfonato-calix[4]resorcinarene hosts and
host-guest complexes. Here, the electrophilic sites are represented as yellow color (positive value),
while the nucleophilic sites are represented as blue color (negative value). The electrostatic poten-
tial map demonstrates that the most applicable atomic sites for electrophilic attack are the sulfonic
group SO2OH at the upper rim of the hosts, while the most possible sites for nucleophilic process
are O−H groups.
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Conclusion
In this work we have studied the calix[4]arenes, calix[4]resorcinarenes and their phosphonate and
sulfonate derivatives as potential drug carriers for the osteoporosis inhibitor drug zoledronate in
host-guest chemistry using ab initio density functional theory calculations. Norm-conserving pseu-
dopotential pseudo atomic orbital method was adopted with the standard DZP basis sets and BLYP
+ vdW (Grimme) GGA functional. After refinement of structures through stochastic conformation
searching, we have conducted full atomic relaxations to obtain the optimized molecular structures
of selected 9 different hosts and 18 different host-guest complexes. Through careful analysis of the
optimized structures, we have concluded that (1) the geometrical size of the cavity of phosphonate
and sulfonate modified hosts are clearly changed upon the insertion of guest ZOD molecule in-
side their cavity, but little change for the free hosts, (2) the calix[4]resorcinarenes support stronger
binding of host-guest coupling than the calix[4]arenes due to additional hydrogen bonding by OH
groups from resorcinol at the upper rim, and (3) the host-guest formations at the ring docking way
is more desirable than the branch way due to additional pi − pi stacking interaction between the
ZOD ring carbon atoms and the host phenyl ring carbon atoms. To get more quantitative assess for
the host-guest complex formations, we have calculated the binding energy in gaseous and aqueous
state, and the frontier molecular orbitals including HOMO and LUMO. Our calculations indicates
that while in gaseous state some complexes can be formed endothermically due to positive binding
energies, in aqueous state all the complexes can be formed exothermically, with larger binding
energies in the branch docking way (−52 ∼ −93 kcal/mol) than the ring docking way (−26 ∼ −85
kcal/mol). The lowest HOMO-LUMO energy gap was found in sulfonato-calix[4]resorcinarenes
(host) and ZOD (guest) complex at the ring docking way. Putting all accounts together, we chose
the sulfonato-calix[4]arenes as the most appropriate host for ZOD guest on 1:1 stoichiometry,
although other hosts are not ruled out. We believe this work will facilitate experimentalists to syn-
thesize real drug carriers for ZOD drug based on calix[n]resorcinarenes as well as contribute to
opening a new road for designing effective drug delivery systems for ZOD drug.
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